In parallel, we also examined the degree of PARK2 mRNA decrease between cancer and corresponding normal tissues from a total number of 13,481 specimens, studied in 127 published microarray datasets (Table S2), covering 25 tumor types. This evidence concerns the gene PRKN and cancer.